| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1537-2995.2001.41070857.X |
| P698 | PubMed publication ID | 11452152 |
| P2093 | author name string | Fuller A | |
| Braine H | |||
| Kickler T | |||
| King K | |||
| Ness P | |||
| Barrasso C | |||
| Blades N | |||
| P2860 | cites work | Transfusion medicine. First of two parts--blood transfusion | Q28296931 |
| The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. | Q33501152 | ||
| Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light | Q42982277 | ||
| The cost-effectiveness of reducing donor exposures with single-donor versus pooled random-donor platelets. | Q53539667 | ||
| P433 | issue | 7 | |
| P921 | main subject | platelet transfusion | Q23925170 |
| P304 | page(s) | 857-861 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | Transfusion | Q15758500 |
| P1476 | title | Single-donor platelets reduce the risk of septic platelet transfusion reactions. | |
| P478 | volume | 41 |
| Q83514166 | A prospective quality evaluation of single donor platelets (SDP) - an experience of a tertiary healthcare center in India |
| Q43030574 | A prospective study to determine the frequency of bacterial contamination of platelets |
| Q39615231 | Addressing the risk of bacterial contamination of platelets within the United States: a history to help illuminate the future |
| Q44720880 | Allergic transfusion reactions to platelets are more commonly associated with prepooled than apheresis components |
| Q54448089 | An incremental solution to bacterial contamination: taking the first step. |
| Q35095789 | Bacterial contamination and transfusion safety: experience in the United States |
| Q35926260 | Bacterial contamination in blood components and preventative strategies: an overview |
| Q33719334 | Bacterial contamination of blood components |
| Q50907907 | Bacterial contamination of blood products at the Croatian Institute of Transfusion Medicine: results of eleven-year monitoring. |
| Q34522392 | Bacterial contamination of blood products: factors, options, and insights |
| Q34302558 | Bacterial contamination of blood: lessons from the past and road map for the future |
| Q35807467 | Bacterial contamination of cellular blood components: risks, sources and control |
| Q34100097 | Bacterial contamination of donor blood at the Tamale Teaching Hospital, Ghana |
| Q50741091 | Bacterial contamination of platelet concentrates prepared by different methods: results of standardized sterility testing in Germany. |
| Q34451446 | Bacterial contamination of platelet concentrates: incidence, significance, and prevention |
| Q93541706 | Bacterial contamination of platelet concentrates: pathogen detection and inactivation methods |
| Q50701322 | Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. |
| Q37638897 | Bacterial contamination of platelets |
| Q35079598 | Bacterial culture reduces but does not eliminate the risk of septic transfusion reactions to single-donor platelets |
| Q44430914 | Bacterial detection and extended platelet storage: the next step forward |
| Q43915979 | Bacterial infections associated with blood transfusion: experience and perspective of infectious diseases consultants |
| Q36681373 | Bacterial risk reduction by improved donor arm disinfection, diversion and bacterial screening |
| Q37715077 | Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality |
| Q34790959 | Comparison of Plateletpheresis on the Fenwal Amicus and Fresenius Com.Tec Cell Separators. |
| Q47566254 | Comparison of Plateletpheresis on the Haemonetics and Trima Accel Cell Separators |
| Q53446579 | Comparison of double dose plateletpheresis on the Fenwal Amicus, Fresenius COM.TEC and Trima Accel cell separators. |
| Q53442652 | Comparison of plateletpheresis on the Fenwal Amicus, Fresenius COM.TEC, and Trima Accel Cell separators. |
| Q41484589 | Comparison of the BACTEC 9240 and BacT/Alert blood culture systems for detection of bacterial contamination in platelet concentrates |
| Q43727179 | Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United States |
| Q51940682 | Costs and benefits of bacterial culturing and pathogen reduction in the Netherlands. |
| Q50879136 | Culture-based bacterial detection systems for platelets: the effect of time prior to sampling and duration of incubation required for detection with aerobic culture. |
| Q26996247 | Current methods for the reduction of blood-borne pathogens: a comprehensive literature review |
| Q35991936 | Current safety of the blood supply in the United States |
| Q44885344 | Don't bug me: the problem of bacterial contamination of blood components--challenges and solutions |
| Q83017103 | Donor selection criteria to maximize double platelet products (DPP) by platelet apheresis |
| Q58125020 | Double Dose Plateletpheresis: A Savior to Shrinking Donor Pool and Platelet Inventory Management |
| Q88121541 | Effectiveness of the Trima Accel cell separator in the double dose plateletpheresis |
| Q33425237 | Effectiveness of the haemonetics MCS cell separator in the collection of apheresis platelets |
| Q38469282 | Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands |
| Q34791060 | Efficacy and Adverse Events of Platelet Transfusion Product-Specific Differences |
| Q43036585 | Emerging infectious agents: do they pose a risk to the safety of transfused blood and blood products? |
| Q37193720 | Evaluation of Mirasol pathogen reduction system by artificially contaminating platelet concentrates with Staphylococcus epidermidis: A pilot study from India |
| Q76400361 | Evaluation of a new generation of plastic culture bottles with an automated microbial detection system for nine common contaminating organisms found in PLT components |
| Q36340230 | Evaluation of transfusion pyrexia: a review of differential diagnosis and management |
| Q83314801 | Evolution of surveillance methods for detection of bacterial contamination of platelets in a university hospital, 1991 through 2004 |
| Q44783536 | Functional characteristics of buffy-coat PLTs photochemically treated with amotosalen-HCl for pathogen inactivation |
| Q33432190 | I am the 9%: Making the case for whole-blood platelets |
| Q51953927 | In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers. |
| Q37208873 | Incidence of bacterial transmission and transfusion reactions by blood components |
| Q46137108 | Listeria monocytogenes in platelets: a case report |
| Q34941812 | Making risk statements stick |
| Q34006006 | Microcalorimetry: a novel method for detection of microbial contamination in platelet products |
| Q47808008 | Monitoring of apheresis platelet bacterial contamination with an automated liquid culture system: a university experience |
| Q33361167 | Optimizing platelet transfusion therapy |
| Q34996364 | Pathogen inactivation of blood components: current status and introduction of an approach using riboflavin as a photosensitizer |
| Q37013124 | Pathogen inactivation: making decisions about new technologies. Report of a consensus conference |
| Q45050105 | Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products. |
| Q35812955 | Pathogen reduction technologies: what are the concerns? |
| Q34803014 | Pharmaco-economics of blood transfusion safety: review of the available evidence |
| Q44410070 | Platelet bacterial contamination: assessing progress and identifying quandaries in a rapidly evolving field |
| Q48658637 | Plateletpheresis efficiency and mathematical correction of software-derived platelet yield prediction: A linear regression and ROC modeling approach |
| Q37595112 | Problem of bacterial contamination in platelet concentrates |
| Q36106339 | Protecting the blood supply from emerging pathogens: the role of pathogen inactivation |
| Q44186272 | Quality control of leucocyte-depleted platelet concentrates obtained by buffy-coat method. |
| Q40834176 | Rapid screening method for detection of bacteria in platelet concentrates |
| Q34447532 | Rational use of blood products |
| Q37209101 | Reduction of the risk of bacterial contamination of blood components through diversion of the first part of the donation of blood and blood components |
| Q42413542 | Results of an educational program to promote the use of pooled instead of single-donor platelet transfusions |
| Q35561977 | Risk and prevention of transfusion-related sepsis |
| Q35122220 | Risks associated with transfusion of cellular blood components in canada |
| Q74332134 | Single-donor platelets reduce the risk of septic platelet transfusion reactions |
| Q36439243 | Streptococcus agalactiae sepsis after transfusion of a plateletpheresis concentrate: benefit of donor evaluation |
| Q45966196 | Summary of the AABB Interorganizational Task Force on Bacterial Contamination of Platelets: Fall 2004 impact survey. |
| Q34791071 | Supply with Platelet Concentrates from the Point of View of a Blood Donation Service of the Bavarian Red Cross |
| Q35265135 | Supportive care in patients with acute leukaemia: historical perspectives |
| Q34560849 | The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. |
| Q34231829 | The hazards of blood transfusion in historical perspective |
| Q33392897 | Thromboembolic and bleeding complications in acute leukemia |
| Q35064110 | Transfusion medicine for the pediatrician |
| Q35047211 | Transfusion medicine: looking to the future |
| Q64126280 | Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module |
| Q35743767 | Transfusion-transmitted bacterial infection: risks, sources and interventions |
| Q50762248 | Use of a pH meter for bacterial screening of whole blood platelets. |
| Q44113335 | Use of random versus apheresis platelet concentrates |
| Q83242107 | [Conventional vs pathogen-inactivated platelet concentrates for the treatment of perioperative coagulopathy. A prospective cohort study] |
| Q79789964 | [New container of sample: role in the reduction of bacterial contamination of standard platelet units] |
Search more.